株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

子宮頸癌:世界の臨床試験レビュー

Cervical Cancer Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 212843
出版日 ページ情報 英文 504 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.15円で換算しております。
Back to Top
子宮頸癌:世界の臨床試験レビュー Cervical Cancer Global Clinical Trials Review, H1, 2017
出版日: 2017年05月31日 ページ情報: 英文 504 Pages
概要

当レポートでは、子宮頸癌治療薬の臨床試験におけるデータを提供し、 国別の動向、臨床試験数、世界における臨床試験所別の募集状況などをまとめ、 概略以下の構成でお届けします。

目次

  • イントロダクション
    • 子宮頸癌
    • レポートガイダンス
  • 臨床試験 領域別
  • 臨床試験 国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位5ヵ国 − 中東およびアフリカ
    • 臨床試験に寄与している上位5ヵ国 − 中南米
  • 臨床試験:BRIC 諸国
  • 臨床試験:G7 諸国
  • 臨床試験:G7 諸国 治験ステータス別
  • 臨床試験:E7 諸国
  • 臨床試験:E7 諸国 治験ステータス別
  • 臨床試験 相別
    • 進行中の治験 相別
  • 臨床試験 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験 プロファイル
    • 臨床試験概要: 上位企業
      • GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Photocure ASA
      • Pfizer Inc.
      • Tigris Pharmaceuticals, Inc.
      • N.V. Mithra Pharmaceuticals S.A.
      • ARCAGY - GINECO
      • MannKind Corporation
      • Zeria Pharmaceutical Co Ltd
      • 大鵬薬品工業
      • 日本化薬
      • Novartis AG
      • VGX Pharmaceuticals Inc.
      • Precision Therapeutics , Inc.
      • Cytokine PharmaSciences, Inc.
      • 第一三共
      • GUIDED Therapeutics , Inc.
      • Inovio Pharmaceuticals, Inc.
      • Eli Lilly and Company
      • Adherex Technologies Inc.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Gynecologic Oncology Group
      • The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • European Organization for Research and Treatment of Cancer
      • University Health Network
      • Tata Memorial Hospital
      • British Columbia Cancer Agency
      • Case Comprehensive Cancer Center
      • Washington University School of Medicine
      • Wake Forest University
      • University of California, Irvine
      • Medical University of Vienna
      • Masonic Cancer Center
      • Duke University
      • Dana-Farber Cancer Institute
      • Radiation Therapy Oncology Group
      • The University of British Columbia
      • Chang Gung Memorial Hospital
      • Abramson Cancer Center
      • University of Alabama at Birmingham
  • 主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4261CTIDB

GlobalData's clinical trial report, "Cervical Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Cervical Cancer 31
  • Jun 02, 2017: Opdivo (nivolumab) Data in Patients with Advanced Cervical, Vaginal and Vulvar Cancers from Phase 1/2 CheckMate -358 Presented at ASCO 31
  • May 18, 2017: Advaxis to Host Investor & Analyst Day on June 12 31
  • Apr 18, 2017: Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer 32
  • Mar 27, 2017: Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac 32
  • Mar 23, 2017: Vaccibody Announces Vaccination Of First Patient In Its Phase IIA Study With VB10.16 Immunotherapy For Patients With HPV16 Induced High Grade Lesions Of The Cervix 32
  • Mar 15, 2017: Advaxis Presents Oral Late-breaking Data on Phase 2 GOG-0265 Study of Axalimogene Filolisbac at SGO's Annual Meeting on Women's Cancer 33
  • Clinical Trial Profile Snapshots 35

Appendix 502

  • Abbreviations 502
  • Definitions 502
  • Research Methodology 503
  • Secondary Research 503
  • About GlobalData 504
  • Contact Us 504
  • Disclaimer 504
  • Source 504

List of Tables

List of Tables

  • Cervical Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures

List of Figures

  • Cervical Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • GlobalData Methodology 503
Back to Top